Spero Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.21

-0.05 (-2.21%)

As of Jun 30, 10:31 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,318.1% upside

Low Target $21.51

Average Target $31.34

High Target $48.77

Current Price $2.21

Current
$2.21

Target
$31.34

$21.51 $31.34 avg $48.77

Scenario Analysis

Bear Case

$21.51

873.3%

Low target

Base Case

$31.34

+1,318.1%

Avg target

Bull Case

$48.77

+2,106.8%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.22

-31.4% from high

52-Week Low

$1.80

+22.8% from low

Target vs 52W High

$31.34

+873.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%